• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ALERE DETERMINE HIV-1/2 AG/AB COMBO; IVD FOR HIV 1/2 AG/AB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ALERE DETERMINE HIV-1/2 AG/AB COMBO; IVD FOR HIV 1/2 AG/AB Back to Search Results
Catalog Number 7D2648
Device Problem False Positive Result (1227)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Information (3190)
Event Date 02/08/2020
Event Type  malfunction  
Manufacturer Narrative
Testing was performed at abbott diagnostics (b)(6), inc.On retained kit lot 115434 with the following internal serum/plasma control samples: (b)(6).All test results were valid and performed as expected.Additionally, the manufacturing batch records for lot 115434 were reviewed.This lot met the required release specifications.A review of the complaints reported as false positive or unconfirmed false positive related to lot number 115434 showed that the complaint rate is (b)(4).The evidence available does not indicate that the product is performing outside label claims.Abbott diagnostics (b)(4), inc.Was unable to determine the exact root cause of the reported issue.The results obtained may possibly be related to the patient sample.The sample may have contained specific substances which may have affected the results.The available evidence suggests that this device lot is performing within labeled claims.
 
Event Description
A customer reported four (4) (b)(6) results with alere determine hiv-1/2 ag/ab combo.This report represents three (3) of four (4).The customer reported a (b)(6) antibody (ab) result on a serum sample with alere determine hiv-1/2 ag/ab combo.Confirmation testing (methodology: molecular viral load) was reported as (b)(6).The patient gender, pregnancy status, treatment and outcome were unknown.The customer stated there was no death or serious injury based on the alere determine hiv-1/2 ag/ab combo result.There is insufficient information to determine if a malfunction occurred.Attempts to gain additional patient information were no successful.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALERE DETERMINE HIV-1/2 AG/AB COMBO
Type of Device
IVD FOR HIV 1/2 AG/AB
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough, me
Manufacturer Contact
erin rowley
10 southgate road
scarborough, me 
7305858
MDR Report Key9851049
MDR Text Key221030788
Report Number1221359-2020-00014
Device Sequence Number1
Product Code MZF
UDI-Device Identifier10811877010293
UDI-Public011081187701029310115434
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BP120037-0
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/04/2021
Device Catalogue Number7D2648
Device Lot Number115434
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/20/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/06/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-